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A B S T R A C TObjective: The six-dimensional health state short form (SF-6D) was
designed to be derived from the short-form 36 health survey (SF-36).
The purpose of this research was to compare the SF-6D index values
generated from the SF-36 (SF-6DSF-36) with those obtained from the SF-
6D administered as an independent instrument (SF-6DInd). The goal
was to assess the consistency of respondents’ answers to these two
methods of deriving the SF-6D. Methods: Data were obtained from a
sample of the Portuguese population (n ¼ 414). Agreement between
the instruments was assessed on the basis of a descriptive system and
their indexes. The analysis of the descriptive system was performed
by using a global consistency index and an identically classiﬁed index.
Agreement was also explored by using correlation coefﬁcients. Para-
metric tests were used to identify differences between the indexes.
Regression models were estimated to understand the relationship
between them. Results: The SF-6DInd generates higher values thansee front matter Copyright & 2013, International S
r Inc.
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o, Portugal.does the SF-6DSF-36. There were signiﬁcant differences between the
indexes across sociodemographic groups. There was a signiﬁcant
ceiling effect in the SF-6DInd but not in the SF-6DSF-36. The correlation
between the indexes was high but less than what was anticipated. The
global consistency index identiﬁed the dimensions with larger differ-
ences. Considerable differences were found in two dimensions, possi-
bly as a result of different item contexts. Further research is needed to
fully understand the role of the different layouts and the length of the
questionnaires in the respondents’ answers. Conclusions: The results
show that as the SF-6D was designed to derive utilities from the SF-36
it should be used in this way and not as an independent instrument.
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Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
The short-form 36 health survey (SF-36) is a 36-item generic
health status instrument, comprising eight scales and two
component summary scales [1,2], which has been extensively
validated and used e.g., [3–12]. The SF-36 is a proﬁle-based
patient-reported outcome measure that yields health scores
across its eight dimensions. It does not, however, generate
utilities, and hence it has a limited use in economic evaluations
of health care interventions or technologies. To overcome this
problem, a decade ago, Brazier et al. [13] developed an algorithm
to translate the SF-36 results into health state utilities. They
created the six-dimensional health state short form (SF-6D), an
econometric preference-based index derived from 11 items of the
SF-36, which are combined into six dimensions of health, with
four to six levels each [13]. The SF-6D describes 18,000 different
health states. A valuation survey was carried out in the United
Kingdom to obtain values to a sample of 249 health states deﬁned
for the SF-6D. A representative sample of the general UK pop-
ulation valued these health states by using the standard gamblemethod. Econometric models were estimated by using the data
collected to predict utility scores for all health states deﬁned by
the SF-6D [14]. These health state values constitute the SF-6D
index, which can be seen as a continuous value ranging from 0.35
to 1.00. Another version of the SF-6D was developed on the basis
of the short-form 12 health survey instrument (SF-12), and utility
scores for all health states deﬁned by this instrument for the UK
population are also available [14]. The SF-6D enables a utility
score to be generated by using responses to the SF-36 or the SF-
12. There are now speciﬁc value sets for the SF-6D for Portugal
[15], Japan [16], Hong Kong [17], and Brazil [18], with value sets for
Australia and Singapore currently being determined.
Given that the SF-36 is widely used all over the world, the use
of the SF-6D as a way of generating utilities from the SF-36 has
increased in recent years and is now one of the preference-based
indexes most widely used in cost-utility analyses and other
studies that aim at measuring individuals’ preferences for health
states [e.g., 19–26] and included in numerous pharmacoeconom-
ics guidelines. Previous research has focused on the assessment
of the performance of the SF-6D and on comparisons with otherociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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questionnaire or the Health Utilities Index. Several articles have
been published on these topics [e.g., 27–34]. It is also useful to
know whether the SF-6D health state classiﬁcation can be used in
its own right because this would be a more efﬁcient way to collect
the data. There are, however, no published studies having been
dedicated to studying the consistency of the SF-6D when the
classiﬁcation system is used directly in a study to derive the
health state of the individual rather than deriving the health
state from responses to the SF-36 or the SF-12. Therefore, we
intend to overcome this gap in the literature by exploring the
consistency of respondents’ answers to these two methods of
deriving the SF-6D.
The aim of this research was twofold: 1) to test the hypothesis
that the SF-6D applied as an independent instrument (SF-6DInd)
produces results different from those obtained from the SF-6D
index generated from the SF-36 (SF-6DSF-36) and 2) to examine
whether the conclusions differed depending on the value
set used.Methods
Sample and Data Collection
Data were collected from a sample of individuals from the adult
general Portuguese (PT) population (n ¼ 414) in spring 2011 in
Portugal. Respondents were recruited from the population of
students and staff of a public university in Portugal, according
to their willingness to participate in the study. Although the
sample used in the study is nonrandom, it was expected to
include respondents from different sociodemographic groups
given that the population of individuals comprised undergradu-
ate and graduate students and teaching and nonteaching staff. In
addition, it was not essential to use a random representative
sample of the general population given that to achieve the aim of
this research it was only necessary to prove that using the SF-
6DInd produces results different from those obtained from the SF-
6DSF-36 in at least one sample.
Respondents self-completed the SF-36v2 and the SF-6D on a
voluntary and anonymous basis. This enables analysis of the
consistency of respondents’ answers to the two above-mentioned
methods of deriving the SF-6D index; the SF-6D was also applied
as an independent questionnaire.
The order of the self-completed paper-and-pencil question-
naires was ﬁxed and was the same throughout the study: ﬁrst,
the SF-36, and second, the SF-6D classiﬁcation system. In addi-
tion, respondents reported information on sociodemographic
variables, such as sex, age, marital status, education, labor
market participation, area of living, income, and the presence
(or not) of a chronic disease.
The UK [14] and the PT [15] value sets for the SF-6D were both
applied to the data collected to further examine whether the
conclusions differed depending on the value set used. We have
applied only these two value sets because there are no other
European value set for the SF-6D and the UK value set is
considered the gold standard. In fact, before the elicitation of
the PT value set, studies conducted in Portugal used UK popula-
tion values.
Statistical Analysis
Sample characteristics were ﬁrst described by computing descrip-
tive statistics for sociodemographic variables. The analysis of the
degree of agreement between instruments was divided into two
parts. First, an analysis based on the classiﬁcation system of both
instruments was performed, that is, an analysis of whatrespondents reported about their health in each instrument. This
task started with a general descriptive analysis of the distribution
of responses across dimensions in both instruments. Then, the
degree of association between dimensions of the SF-6D was
measured by using the Spearman’s correlation coefﬁcient. In
addition, we used the following two measures based on square
two-way contingency tables: a global consistency index (GCI) and
an identically classiﬁed index (ICI). The GCI computes the
percentage of individuals classiﬁed in the same level of each
dimension in both instruments and is given by
GCI¼
∑lj¼1njj
n
 100, ð1Þ
where n is the sample dimension and njj is the number of
individuals with response in the same level j (j ¼ 1, …, l) of a
particular dimension in the SF-6DSF-36 and in the SF-6DInd. The
GCI will be equal to 100 if all individuals equally respond on a
speciﬁc dimension in both instruments. GCI values above 75 are
interpreted as a strong agreement between instruments, whereas
GCI values ranging from 50 to 75 are considered as a moderate
agreement. GCI values lower than 50 suggest a poor agreement.
The ICI calculates the percentage of individuals correctly classi-
ﬁed in a level j of each dimension in the SF-6DInd and is given by
ICIj¼
njj
njd
 100, ð2Þ
where njd¼∑lk¼1njk is the total number of responses in level j of a
particular dimension in the SF-6DSF-36. The ICI can be interpreted
as a stability indicator and will be equal to 100 if all individuals
equally respond on a level j of a speciﬁc dimension in both
instruments. We also deﬁne a poor level of stability on responses
when the ICI is less than or equal to 25.
Second, an analysis of the preference-based indexes gener-
ated by the instruments was carried out by using the following
data analysis: 1) basic descriptive statistics including means,
medians, and ranges to compare the main features of the
indexes; 2) skewness statistics and one-sample Kolmogorov-
Smirnov tests to evaluate the asymmetry and normality of
distributions; 3) ceiling and ﬂoor effects (proportion of respond-
ents with the best and worst possible theoretical scores, respec-
tively) were identiﬁed; 4) Pearson’s correlation coefﬁcients to
study the association between instruments and intraclass corre-
lation coefﬁcients (ICCs) based on a two-way mixed model with
absolute agreement, for a global assessment of the agreement
between indexes; 5) paired-samples t test (related-samples Wil-
coxon signed-rank tests) to identify mean (median) differences
between the indexes; and 6) regression analysis to explore the
nature of their relationship. We have used the following model:
Yi¼αþβXiþεi, ð3Þ
where Y represents the SF-6DSF-36 index, X the SF-6DInd index, ε
the residuals, and i respondents (i ¼ 1, …, n). It should be noted,
however, that the aim of the regression analysis was to test
whether there is a perfect agreement between the indexes and
not to explain or predict the SF-6DSF-36 index through the SF-6DInd
index. Because an agreement between the indexes would result
in estimated models in which the constant (α) would be equal to
zero and the slope (β) equal to one, hypothesis tests were
performed to verify these assumptions. Finally, the pattern of
agreement was also examined graphically by plotting values
obtained for the UK and PT value sets.
It should be noted that mean differences between indexes
were evaluated by using paired-samples t tests, although the
normality assumption was not veriﬁed. This decision was based
on the following: the large sample size of our study; the well-
known result that the power of the Kolmogorov-Smirnov Z test
increases with the sample size; and some evidence that
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the same conclusions to those of parametric methods, and that
the latter are, thereby, robust to violation of assumptions such as
normality [32]. Although we do not report detailed results, we
have veriﬁed whether the conclusions were the same by using
nonparametric tests. The purposes of the subgroup analyses
performed were to understand whether there were signiﬁcant
differences between the subgroups and to identify the subgroups
in which there were most likely to be the differences. All data
analyses were performed by using the IBM SPSS Statistics version
19.0 package.Results
Table 1 shows the main characteristics of the study sample. Age
ranged from 16 to 70 years, with a mean age of 28 (SD¼9.7). Of the
respondents, 64.6% were women, 69.2% were single, and 54.5%
had a middle education level. Furthermore, only 45.1% were
actively employed, 35.4% earned less than €1000 per month,
79.3% lived in urban areas, and 77.5% did not report a chronic
disease.
An inspection of the distributions of individuals’ responses
across dimensions of the two instruments (Table 2) revealed that
there was a considerable percentage of responses in different
levels of the same dimension in the SF-6DInd and the SF-6DSF-36. If
it was acceptable to use the SF-6D as an independent instrument,
we would expect respondents to report the same level in a
speciﬁc dimension, whatever the instrument used; that is, dis-
tributions in two-way contingency tables would be near diagonal
matrices.Table 1 – Study sample characteristics.
Sociodemographic variables n (%)
Sex
Female 267 (64.6)
Male 146 (35.4)
Age group (y)
r20 92 (22.7)
21–40 264 (65.0)
440 50 (12.3)
Marital status
Single 285 (69.2)
Married/living together 113 (27.4)
Divorced/separated 10 (2.4)
Widowed 4 (1.0)
Educational level
Low 14 (3.4)
Middle 225 (54.5)
High 174 (42.1)
Relation to the labor market
Actively employed 185 (45.1)
Actively unemployed 12 (2.9)
Inactive 213 (52.0)
Area of living
Urban area 326 (79.3)
Rural area 85 (20.7)
Income (€/month)
o1000 142 (35.4)
1000–2000 153 (38.3)
42000 105 (26.3)
Chronic disease
Yes 89 (22.5)
No 307 (77.5)For an in-depth analysis of the level of agreement, we have
computed measures of agreement between instruments for each
dimension, based on the respondents’ self-reported health,
which are presented in Table 3. In this table, we also present
the distribution of responses in each dimension of the SF-6DSF-36.
Because results were the same whatever the value set used (PT or
UK), we decided to not refer the value set in that table. Although
it was observed that individuals responded differently on the
same dimension of the instruments, one would expect to ﬁnd
strong direct correlations between the same dimension in the SF-
6DInd and the SF-6DSF-36 because the Spearman’s correlation
coefﬁcient assesses how well the relationship between two
variables can be described but does not measure whether the
rank values are the same in both variables. That was the case
because all the correlations were statistically signiﬁcant and
some of them can be seen as moderate/strong. Indeed, the
highest correlation of 0.667 was found between the responses
in these instruments for pain, followed by the correlation
between the responses for physical functioning (ρ ¼ 0.570) and
social functioning (ρ ¼ 0.566). The lowest correlation was
observed between the responses in these instruments for role
limitations (ρ ¼ 0.412).
An analysis of the results of the GCI reveals important differ-
ences in the level of agreement in responses across the dimen-
sions of the SF-6D. For example, 69.2% of the individuals
responded at the same level in the SF-6DInd and the SF-6DSF-36
for physical functioning [GCIphysical functioning ¼ (215 þ 68 þ 2 þ 0 þ
0 þ 0)  100/412 ¼ 69.2]. In contrast, only 25.2% of the individuals
responded at the same level for vitality and 28.2% for mental
health. Although some of the GCI values can be seen as moderate
(e.g., physical functioning, social functioning, and pain), none of
them shows a strong agreement between the instruments.
This evidence is also supported by the results of the ICI.
Agreement between responses in each level is far from perfect.
Indeed, in level 1 of each dimension (no problems), there is good
agreement because all ICI values were above 84% [e.g., ICI1, physical
functioning ¼ 215  100/229 ¼ 93.9, ICI1, role limitations ¼ 138  100/146
¼ 94.5]. Instability on responses, however, is evident in worst
categories. For example, there is no agreement in the most severe
levels (extreme problems) for physical functioning, social func-
tioning, pain, and vitality, but the number of respondents who
reported their health in these levels is too small to merit general-
ization. A poor level of stability on responses was observed in
level 3 of physical functioning, levels 3 and 4 of role limitations,
levels 3 and 5 of pain, and levels 3 and 4 of mental health and
vitality in which there are larger numbers. This means that at
least 75% of those reporting these speciﬁc levels in the SF-6DSF-36
did not equally rate their health using the SF-6DInd.
Descriptive statistics of the SF-6D indexes are presented in
Table 4. First, it should be noted that SF-6DInd modal scores are
equal to one using both the UK and PT value sets. The mean
scores of SF-6DSF-36 (PT) and SF-6DInd (UK) are lower than the
median scores, while the mean scores of SF-6DInd (PT) and SF-
6DSF-36 (UK) slightly exceed the median scores. The Kolmogorov-
Smirnov Z test showed non-normal data distribution for all
four indexes. The skewness results, however, show that depar-
tures from symmetry are not remarkable, particularly for the
SF-6DSF-36 (UK).
Furthermore, the SF-6DInd generated higher scores than did
the SF-6DSF-36 whatever the value set used (PT or UK). Indeed, all
descriptive statistics of central tendency computed for SF-6DInd
utility scores clearly and systematically exceed those computed
for the SF-6DSF-36 utility scores (Table 4). These results were
conﬁrmed by the results of paired-samples t tests and related-
samples Wilcoxon signed-rank tests. These tests conﬁrm
the existence of statistically signiﬁcant mean and median differ-
ences, respectively, between indexes generated by the SF-6DSF-36
Table 2 – Distributions of individuals’ responses across the dimensions of the two instruments.
Physical functioning Pain
SF-6DSF-36 SF-6DInd Σ SF-6DSF-36 SF-6DInd Σ
1 2 3 4 5 6 1 2 3 4 5 6
1 215 10 0 1 3 0 229 1 116 5 2 0 0 0 123
2 57 68 12 0 0 0 137 2 23 51 14 3 1 0 92
3 11 22 2 0 0 0 35 3 23 56 30 11 2 0 122
4 0 0 0 0 0 0 0 4 8 13 13 14 4 0 52
5 1 4 1 0 0 0 6 5 0 1 3 10 3 0 17
6 3 2 0 0 0 0 5 6 1 0 0 0 1 0 2
Σ 287 106 15 1 3 0 412 Σ 171 126 62 38 11 0 408
Role limitations Mental health
SF-6DSF-36 SF-6DInd Σ SF-6DSF-36 SF-6DInd Σ
1 2 3 4 1 2 3 4 5
1 138 5 2 1 146 1 43 3 2 0 0 48
2 18 6 0 0 24 2 95 55 2 1 0 153
3 90 7 26 0 123 3 52 79 10 3 0 144
4 58 23 21 15 117 4 8 30 14 5 1 58
Σ 304 41 49 16 410 5 1 0 2 3 3 9
Σ 199 167 30 12 4 412
Social functioning Vitality
SF-6DSF-36 SF-6DInd Σ SF-6DSF-36 SF-6DInd Σ
1 2 3 4 5 1 2 3 4 5
1 189 16 3 0 0 208 1 22 4 0 0 0 26
2 67 43 7 1 0 118 2 100 61 3 1 0 165
3 19 21 16 0 0 56 3 38 74 12 5 0 129
4 3 8 5 11 0 27 4 13 37 16 8 1 75
5 2 0 0 1 0 3 5 1 1 6 6 0 14
Σ 280 88 31 13 0 412 Σ 174 177 37 20 1 409
SF-36, short-form 36 health survey; SF-6D, six-dimensional health state short form; SF-6DSF-36, SF-6D index values generated from the SF-36; SF-6DInd, SF-6D index values generated from the SF-
6D administered as an independent instrument.
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Table 3 – Rank correlations, GCI, and ICI between instruments for each dimension.
Dimension Spearman correlation GCI ICI (n)
1 2 3 4 5 6
Physical functioning 0.570* 69.2 93.9 (229) 49.6 (137) 5.7 (35) ND (0) 0.0 (6) 0.0 (5)
Role limitations 0.412* 45.1 94.5 (146) 25.0 (24) 21.1 (123) 12.8 (117) – –
Social functioning 0.566* 62.9 90.9 (208) 36.4 (118) 28.6 (56) 40.7 (27) 0.0 (3) –
Pain 0.667* 52.5 94.3 (123) 55.4 (92) 24.6 (122) 26.9 (52) 17.6 (17) 0.0 (2)
Mental health 0.499* 28.2 89.6 (48) 35.9 (153) 6.9 (144) 8.6 (58) 33.3 (9) –
Vitality 0.504* 25.2 84.6 (26) 37.0 (165) 9.3 (129) 10.7 (75) 0.0 (14) –
ND, not deﬁned (there were no responses).
 P o .001.
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value sets. In Table 4, we can also observe that mean differences
between the SF-6DInd and the SF-6DSF-36 utility scores are stron-
ger when the UK value set is used (PT: 0.066; UK: 0.121).
Similar conclusions were obtained by sociodemographic char-
acteristics (Table 5), although few statistically signiﬁcant differ-
ences between sociodemographic subgroups exist. Mean scores of
all indexes were considerably higher for males than for females,
and higher in the subgroup who did not report a chronic disease.
Table 4 shows that ﬂoor effects were not observed on all
indexes. The SF-6DInd indexes, however, showed a non-negligible
ceiling effect, with 27.5% and 18.4% of the individuals having the
highest possible score when using the PT and the UK value sets,
respectively. This compares to a ceiling effect of 2.0% and 1.2%,
respectively, for the SF-6DSF-36 indexes. The ceiling effect of the SF-
6DInd indexes varies substantially across different sociodemo-
graphic groups, even though it presents approximately the same
distribution for both value sets, which is expected given that the
underlying health state is the same regardless of the value set
applied (Table 6). For example, the ceiling effect for males is visibly
larger than that for females; the ceiling effect in the middle
education subgroup is slightly larger than that in the high
education subgroup and is zero in the low education subgroup;
the ceiling effect in the subgroup who reported chronic disease is
considerably smaller than that in the opposing subgroup.
Over the study sample, the SF-6DSF-36 and SF-6DInd scores were
correlated, although far from a perfect correlation, regardless of the
value set used (PT: r ¼ 0.677, ICC ¼ 0.467; UK: r ¼ 0.709, ICC¼ 0.473).Table 4 – Descriptive statistics of the indexes on the stu
SF-6DSF-36 (PT)
Observed range (theoretical: 0.35–1.00) 0.62–1.00
Mode 0.922
Mean (SD) 0.861 (0.075)
Median (IQR) 0.881 (0.81–0.92)
KS Z test 0.128*
Skewness (SE) 0.843 (0.323)
Ceiling effect (%) 1.96
Mean difference† 0.066*
Median difference‡ 0.043*
Pearson correlation 0.677*
ICC 0.467*
ICC, intraclass correlation coefﬁcient; IQR, interquartile range; KS, Kolmo
36 health survey; SF-6D, six-dimensional health state short form; SD, st
SF-36; SF-6DInd, SF-6D index values generated from the SF-6D administe
 P o .001.
† According to paired-samples t test.
‡ According to related-samples Wilcoxon signed-rank tests.While the correlation between the SF-6DSF-36 and SF-6DInd scores
was higher when the UK value set was used for the overall sample,
there were some subgroups in which we observe the opposite
(Table 5). In Table 5, we can also observe that perfect correlations
do not exist between indexes in any subgroup and the level of
correlation varied according to sociodemographic characteristics.
The plot of the SF-6DSF-36 to the SF-6DInd (Fig. 1) shows a
substantial deviation from the line that would be indicative of the
perfect agreement between the two measures (i.e., the 45-degree
line from the origin of 0.40–1), with a high percentage of observa-
tions below that line (88.1% and 87.8%, respectively, in the case of PT
and UK value sets). The plots clearly demonstrate the ceiling effects
in the SF-6DInd. These plots suggest that estimated linear regression
models would not have constant equal to zero and slope equal to
one. This conjecture was conﬁrmed by the estimated coefﬁcients,
respectively, presented below each scatter plot of Figure 1 and by
their P values associated with the following null hypothesis: α ¼ 0
and β ¼ 1. All P values were less than .001 in both models. Thus, the
coefﬁcients indicate that the relationship differs under the value set
used. Furthermore, both estimated models had a constant statisti-
cally signiﬁcantly different to zero and slope different to one.Discussion
This study aimed at exploring the consistency of the SF-6D by
comparing the results of SF-6DSF-36 with those of SF-6DInd. The PT
and UK country-speciﬁc value sets were used to examine whetherdy sample.
SF-6DInd (PT) SF-6DSF-36 (UK) SF-6DInd (UK)
0.67–1.00 0.42–1.00 0.52–1.00
1.000 0.887 1.000
0.927 (0.066) 0.729 (0.117) 0.850 (0.124)
0.924 (0.88– 1.00) 0.714 (0.64–0.83) 0.884 (0.76–0.96)
0.137* 0.090* 0.114*
0.827 (0.325) 0.203 (0.123) 0.595 (0.220)
27.45 1.23 18.38
0.121*
0.170*
0.709*
0.473*
gorov-Smirnov; PT, Portuguese; SE, standard error; SF-36, short-form
andard deviation; SF-6DSF-36, SF-6D index values generated from the
red as an independent instrument..
Table 5 – Index means, mean differences, and levels of correlation by sociodemographic characteristics.
Sociodemographic
variables
PT value set UK value set
SF-6DSF-36 SF-6DInd Mean
difference*
Pearson
correlation
ICC SF-6DSF-36 SF-6DInd Mean
difference*
Pearson
correlation
ICC
Sex
Female 0.851 0.915 0.064† 0.696† 0.497† 0.709 0.828 0.119† 0.719† 0.479†
Male 0.880 0.949 0.069† 0.577† 0.346† 0.766 0.890 0.124† 0.646† 0.404†
t test‡ 3.882† 5.101† 4.727† 5.028†
Age group (y)
r20 0.867 0.932 0.065† 0.601† 0.428† 0.732 0.860 0.128† 0.679† 0.436†
21–40 0.859 0.928 0.068† 0.674† 0.440† 0.727 0.852 0.124† 0.704† 0.450†
440 0.857 0.912 0.055† 0.796† 0.635† 0.732 0.822 0.090† 0.780† 0.642†
F test§ 0.741 1.712 0.168 1.580
Marital status
Single 0.861 0.929 0.068† 0.641† 0.432† 0.726 0.851 0.125† 0.682† 0.441†
Married/living together 0.861 0.923 0.061† 0.745† 0.543† 0.737 0.850 0.113† 0.765† 0.544†
Divorced/separated 0.879 0.942 0.063† 0.902† 0.602† 0.747 0.873 0.126† 0.886† 0.596†
Widowed 0.830 0.897 0.067 0.829 0.636J 0.681 0.751 0.070 0.874 0.543
F test§ 0.418 0.680 0.447 0.977
Educational level
Low 0.809 0.878 0.069† 0.858† 0.607† 0.661 0.765 0.104† 0.836† 0.626†
Middle 0.861 0.931 0.070† 0.622† 0.416† 0.730 0.859 0.129† 0.677† 0.433†
High 0.866 0.926 0.060† 0.731† 0.518† 0.733 0.845 0.112† 0.738† 0.510†
F test§ 3.615J 4.404J 2.391 4.027J
Chronic disease
Yes 0.831 0.888 0.057† 0.798† 0.610† 0.696 0.783 0.087† 0.738† 0.630†
No 0.868 0.937 0.069† 0.610† 0.394† 0.738 0.868 0.130† 0.675† 0.416†
t test‡ 4.430† 6.428† 3.190 5.848†
ANOVA, analysis of variance; ICC, intraclass correlation coefﬁcient; PT, Portuguese; SF-36, short-form 36 health survey; SF-6D, six-dimensional health state short form; SF-6DSF-36, SF-6D index
values generated from the SF-36; SF-6DInd, SF-6D index values generated from the SF-6D administered as an independent instrument.
 According to paired-samples t test, but the conclusions were the same if related-samples Wilcoxon signed-rank tests were used.
† P o .001.
‡ According to independent-samples t test, but the conclusions were the same if independent-samples Mann-Whitney U tests were used.
§ According to one-way ANOVA, but the conclusions were the same if independent-samples Kruskal-Wallis tests were used.
J P o .05.
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Table 6 – Ceiling effect (%) by sociodemographic characteristics.
Sociodemographic variables PT UK
SF-6DSF-36 SF-6DInd SF-6DSF-36 SF-6DInd
Sex
Female 0.8 20.1 0.4 12.5
Male 4.2 41.0 2.8 29.2
Age group (y)
r20 5.4 34.1 3.3 16.5
21–40 0.8 26.4 0.8 20.3
440 0.0 18.4 0.0 8.2
Marital status
Single 2.8 29.1 1.8 19.5
Married/living together 0.0 22.5 0.0 15.3
Divorced/separated 0.0 40.0 0.0 30.0
Widowed 0.0 25.0 0.0 0.0
Educational level
Low 0.0 0.0 0.0 0.0
Middle 2.7 29.1 1.8 19.3
High 1.2 27.5 0.6 18.7
Chronic disease
Yes 0.0 9.3 0.0 7.0
No 2.3 32.8 1.3 21.3
PT, Portuguese; SF-36, short-form 36 health survey; SF-6D, six-dimensional health state short form; SF-6DSF-36, SF-6D index values generated
from the SF-36; SF-6DInd, SF-6D index values generated from the SF-6D administered as an independent instrument.
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 0 2 3 – 1 0 3 1 1029the conclusions differed depending on the value set used. The SF-
6DInd generates higher values than does the SF-6DSF-36 using both
country value sets. There were also signiﬁcant differences
between the indexes across sociodemographic groups.
We found a signiﬁcant ceiling effect in the SF-6DInd not
observed in the SF-6DSF-36. Moreover, this ceiling effect of the SF-
6DInd index varied substantially across different sociodemographic
groups. If this variability just reﬂected the fact that men, young,
those with a high income, and those without chronic disease areFig. 1 – Relationship between the distribution of the SF-6DSF-36 a
form 36 health survey; SF-6D, six-dimensional health state short
36; SF-6DInd, SF-6D index values generated from the SF-6D admhealthier, this would be expected; however, the same results
should also be expected in the SF-6DSF-36, but this was not the case.
As mentioned before, many items in the SF-36 are used to
generate the SF-6DSF-36 whereas each SF-6DInd dimension is
generated by using only one item. Our results showed that the
use of the SF-6D descriptive system directly led the individuals to
answer on the higher level. To understand this ﬁnding, we may
speculate that a larger context of questions, that is, a larger range
for the concept to be measured, may change the relative locationnd the SF-6DInd utility scores (whole sample). SF-36, short-
form; SF-6DSF-36, SF-6D index values generated from the SF-
inistered as an independent instrument.
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 0 2 3 – 1 0 3 11030of a particular question and so, the stimulus given to the
respondent.
Furthermore, the ordering of the questionnaires in the survey
meant that respondents always completed the SF-36 ﬁrst, mean-
ing by the time they reached the SF-6D classiﬁcation system they
had already completed many similar questions about their
health. There are few studies in the literature that address issues
related to order effects. A recent study [35], however, showed a
tendency to not use the “in-between” levels when a longer
version of a questionnaire was ﬁrst scored than the original
version. Therefore, in our opinion, changing the order of the
instruments could have introduced “noise” in the study and
probably inﬂuenced the results.
The results show that the SF-6D should be derived from the
SF-36/SF-12 responses and should not be used as an independent
instrument where respondents are asked to complete the classi-
ﬁcations system alone because this will lead to different
responses and different utility values. The ﬁndings provide
evidence that moving from the SF-6DSF-36 to the SF-6DInd involves
differences in the mean index values across all sociodemographic
groups.
Although these results should not be generalized to other
instruments, similar results could have been found if the Health
Utilities Index mark 2 and 3 have been used because the latter
have been adapted from the ﬁrst. Arguably, these results could
also apply to any other instrument in which a health state is
derived from a longer instrument, including a number of
condition-speciﬁc measures, such as the Asthma Quality of Life
Questionnaire, the Overactive Bladder Questionnaire, or the
European Organisation for Research and Treatment of Cancer
questionnaire, from which preference-based single indexes have
been derived. We hope that the methodology presented here can
be of assistance in further studies on these issues.
The differences found constitute an important and worrying
result, and the reasons should be further investigated. But why
should we expect no differences? Overall, there is no reason why
the instruments should give the same results. Some random
differences would be expected because of measurement error—
people simply make mistakes at each administration, but this
should not result in any overall differences. A greater error might
be expected in well-being items than in functioning, and this
would be translated into greater differences. This may explain
why mental health and vitality have lower agreement, but it is
not a reason for bias. Similar to this is that the well-being items—
mental health and vitality— responses are more evenly distrib-
uted (i.e., far fewer at 1.0) and so there is more scope for error.
Those with large numbers at level 1 are bound to show higher
levels of agreement. Again, this is not a reason for bias but may
explain differences in the GCI. It could also be expected that
those dimensions made up one item—such as vitality—to have
more error because those composed of two or three SF-36 items
could be more reliable.
Other reasons that could explain main differences concern
the way respondents dealt with end points of the scales, the
number of items used, and the context. In truth, the literature
suggests that respondents avoid the ends of a scale (end-point
bias); however, this was not the case for these respondents. In
cases in which more than one item is used, there is more chance
of indicating a problem in the SF-36 than in the SF-6D. This does
not, however, explain the result for vitality.
The most likely explanation, however, is context. Our
responses to items are altered by the context—in this case, the
other items being completed, particularly those completed just
before. In this case, it may be that completing items in the
context of other related items—such as the 10 physical function-
ing items or the well-being items for mental health and vitality—
makes us more likely to own up to problems we may have.Although when we complete one per dimension, it is more of an
overview and so we tend to generalize to “no problem.” One way
to try to fully understand this would be to 1) repeat in a patient
group; 2) repeat for other instruments, such as the condition-
speciﬁc ones, such as the Asthma Quality of Life Questionnaire or
the Health Utilities Index mark 3; and 3) undertake some
qualitative work.
The overall implications of these ﬁndings may extend beyond
the SF-6D to any short-form version of an instrument. Recently,
there has been a big push to develop short-form instruments
based on subsets of items derived by using Rasch or item
response theory (e.g., patient-reported outcomes), and this
research suggests that this may have implications for how items
are completed.
The sample used (nonrandom sample) and its speciﬁc char-
acteristics that mean it is not representative of the PT population
(e.g., youth) could be considered as a limitation of this study.
Arguably, however, this does not constitute a real drawback of
the study. We strongly believe that although women and young
people are overweighed in the sample, this does not have a
signiﬁcant impact on the conclusions of the study given the aim
of this study. In fact, it is sufﬁcient to show in a particular case
that the SF-6D cannot be applied independently to prove that it is
not valid in all cases.
The study, however, has a limitation that should be men-
tioned: the health states observed. Given that the sample was
relatively young, the number of severe health states was low. The
ﬁndings showed no agreement in the most severe levels (extreme
problems) for physical functioning, social functioning, pain, and
vitality. Because the number of respondents who reported their
health in these levels was low, it was not possible to generalize
the conclusions. Ideally, this would be done with a better
distribution of ratings. Therefore, further research is encouraged
to determine whether the same relationship between the indexes
is observed for a sicker patient population.
Further research is needed to understand why respondents
did not give similar answers when the SF-6D classiﬁcation
system was used directly and to fully understand the role of
the different layouts and the length of the questionnaires in the
respondents’ answers. Qualitative research is recommended. For
instance, following completion of the instruments, respondents
could be shown their answers and asked to consider the reasons
for any discrepancies. It would also be useful to implement a
talk-aloud protocol to better understand the meaning given by
the respondents to the wording of the instruments.Conclusions
The results of this study provide evidence that the SF-6D should
not be used as an independent instrument. It was designed to
derive utilities from the SF-36 (or the SF-12) and should be used in
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